
The U.S. FDA has seized numerous counterfeit units of Ozempic, a popular diabetes drug used for weight loss, distributed through legitimate channels. As five linked illnesses have been reported, the FDA and drug maker Novo Nordisk are testing the seized shots for identity, quality, and safety. While none were serious, some fake 1mg semaglutide shots may still be in circulation. Counterfeit items include needles, pen labels, cartons, and health information. The FDA recommends pharmacies source Ozempic from authorized distributors, urging consumers to obtain it solely from state-licensed pharmacies and report suspicious packages.
Like
Save
Share